Australia, Jan. 29 -- PADAGIS US LLC, owns the trademark (2597212) for 'PADAGIS NALOXONE' and 'CHEVRON DIVIDES GREEK CROSS' till May 26, 2035.
Status: protected:
Registered/protected
Classes: 5 [Medicinal preparations used as a narcotic antagonist; pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations.], 10 [Medical kits consisting of intranasal drug delivery devices, spray pump devices for nasal delivery, and training kits with devices for nasal delivery, sold empty.], 20 [Medicine cabinets.], 35 [Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose; online pharmacy services.] and 44 [Medical and health information services; providing information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips for patients, medical professionals, and pharmacists, via a website; providing pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists, via a website.]
Type of Mark: Figurative
Date of Acceptance: Nov. 20, 2025
Registration Advertised: Jan. 28
For further details contact Madderns Pty. Ltd. and Bregman and Goller Wolff.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2597212.
Disclaimer: Curated by HT Syndication.
